{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:13:13Z","timestamp":1789708393761,"version":"4.0.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.modpat.2023.100323","type":"journal-article","created":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T04:13:31Z","timestamp":1694232811000},"page":"100323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Genomic Profiling of Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System Suggests Novel Potential Therapeutic Targets"],"prefix":"10.1016","volume":"36","author":[{"given":"Claudio","family":"Agostinelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Morandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Righi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marica","family":"Iommi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Tonon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Mazzatenta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Zoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianmarco","family":"Bagnato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Broccoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Lodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Luigi","family":"Zinzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Sabattini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Giannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5035-2448","authenticated-orcid":false,"given":"Sofia","family":"Asioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.modpat.2023.100323_bib1","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"300","article-title":"Primary diffuse large B-cell lymphoma of the CNS","author":"Kluin","year":"2017"},{"key":"10.1016\/j.modpat.2023.100323_bib2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/1756285608101222","article-title":"Primary CNS lymphoma","volume":"2","author":"Schlegel","year":"2009","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.modpat.2023.100323_bib3","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1038\/leu.2011.169","article-title":"Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma","volume":"25","author":"Deckert","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.modpat.2023.100323_bib4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jocn.2020.11.031","article-title":"GCB-type is a favorable prognostic factor in primary CNS diffuse large B-cell lymphomas","volume":"83","author":"Marcus","year":"2021","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.modpat.2023.100323_bib5","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/s12885-016-2397-8","article-title":"MYC and BCL2 overexpression is associated with a higher class of Memorial Sloan-Kettering Cancer Center prognostic model and poor clinical outcome in primary diffuse large B-cell lymphoma of the central nervous system","volume":"16","author":"Kim","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.modpat.2023.100323_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2020.151610","article-title":"Analysis of primary central nervous system large B-cell lymphoma in the era of high-grade B-cell lymphoma: detection of two cases with MYC and BCL6 rearrangements in a cohort of 12 cases","volume":"48","author":"Pina-Oviedo","year":"2020","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.modpat.2023.100323_bib7","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1200\/JCO.1998.16.3.859","article-title":"Long-term survival in primary CNS lymphoma","volume":"16","author":"Abrey","year":"1998","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.modpat.2023.100323_bib8","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.modpat.2023.100323_bib9","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.modpat.2023.100323_bib10","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","article-title":"A\u00a0Probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications","volume":"37","author":"Wright","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.modpat.2023.100323_bib11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.modpat.2023.100323_bib12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2353\/jmoldx.2006.050083","article-title":"FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue","volume":"8","author":"Ventura","year":"2006","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.modpat.2023.100323_bib13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s12022-021-09669-y","article-title":"Intron 4-5 hTERT DNA hypermethylation in Merkel cell carcinoma: frequency, association with other clinico-pathological features and prognostic relevance","volume":"32","author":"Ricci","year":"2021","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.modpat.2023.100323_bib14","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00428-019-02656-z","article-title":"Prognostic impact of intra-field heterogeneity in oral squamous cell carcinoma","volume":"476","author":"Gabusi","year":"2020","journal-title":"Virchows Arch"},{"key":"10.1016\/j.modpat.2023.100323_bib15","doi-asserted-by":"crossref","first-page":"W3","DOI":"10.1093\/nar\/gkw343","article-title":"The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2016 update","volume":"44","author":"Afgan","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.modpat.2023.100323_bib16","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.modpat.2023.100323_bib17","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10014-022-00427-4","article-title":"Clinicopathological risk factors for a poor prognosis of primary central nervous system lymphoma in elderly patients in the Tohoku and Niigata area: a multicenter, retrospective, cohort study of the Tohoku Brain Tumor Study Group","volume":"39","author":"Asano","year":"2022","journal-title":"Brain Tumor Pathol"},{"key":"10.1016\/j.modpat.2023.100323_bib18","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1158\/1078-0432.CCR-11-0395","article-title":"Primary central nervous system lymphomas: a validation study of array-based comparative genomic hybridization in formalin-fixed paraffin-embedded tumor specimens","volume":"17","author":"Braggio","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.modpat.2023.100323_bib19","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00401-012-1064-7","article-title":"Genes regulating the B cell receptor pathway are recurrently mutated in primary central nervous system lymphoma","volume":"124","author":"Montesinos-Rongen","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.modpat.2023.100323_bib20","doi-asserted-by":"crossref","first-page":"5065","DOI":"10.18632\/oncotarget.2080","article-title":"Mutational analysis of primary central nervous system lymphoma","volume":"5","author":"Bruno","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.modpat.2023.100323_bib21","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/leu.2014.264","article-title":"The mutational pattern of primary lymphoma of the central nervous system determined by whole-exome sequencing","volume":"29","author":"Vater","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.modpat.2023.100323_bib22","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1038\/s41467-022-30050-y","article-title":"The genomic and transcriptional landscape of primary central nervous system lymphoma","volume":"13","author":"Radke","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.modpat.2023.100323_bib23","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.3109\/10428194.2014.979413","article-title":"Primary diffuse large B-cell lymphomas of central nervous system exhibit remarkably high prevalence of oncogenic MYD88 and CD79B mutations","volume":"56","author":"Yamada","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.modpat.2023.100323_bib24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1182\/bloodadvances.2018027672","article-title":"MYD88 L265P mutation and CDKN2A loss are early mutational events in primary central nervous system diffuse large B-cell lymphomas","volume":"3","author":"Nayyar","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.modpat.2023.100323_bib25","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/neuonc\/noy193","article-title":"Introduction of novel agents in the treatment of primary CNS lymphoma","volume":"21","author":"Grommes","year":"2019","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.modpat.2023.100323_bib26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejca.2019.05.024","volume":"117","author":"Soussain","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.modpat.2023.100323_bib27","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.ccell.2017.04.012","article-title":"Inhibition of B cell receptor signaling by ibrutinib in primary CNS lymphoma","volume":"31","author":"Lionakis","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.modpat.2023.100323_bib28","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1158\/2159-8290.CD-17-0613","article-title":"Ibrutinib unmasks critical role of Bruton tyrosine kinase in primary CNS lymphoma","volume":"7","author":"Grommes","year":"2017","journal-title":"Cancer Discov"},{"issue":"3","key":"10.1016\/j.modpat.2023.100323_bib29","article-title":"MYD88 L265P mutation in primary central nervous system lymphoma is associated with better survival: a single-center experience","volume":"7","author":"Curran","year":"2021","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.modpat.2023.100323_bib30","article-title":"PIM1 and CD79B mutation status impacts the outcome of primary diffuse large B-cell lymphoma of the CNS","volume":"12","author":"Zhou","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.modpat.2023.100323_bib31","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1016\/j.wneu.2017.12.028","article-title":"MyD88 mutation in elderly predicts poor prognosis in primary central nervous system lymphoma: multi-institutional analysis","volume":"112","author":"Takano","year":"2018","journal-title":"World Neurosurg"},{"key":"10.1016\/j.modpat.2023.100323_bib32","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/bjh.14080","article-title":"MYD88 (L265P) mutation is associated with an unfavourable outcome of primary central nervous system lymphoma","volume":"177","author":"Hattori","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.modpat.2023.100323_bib33","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s12032-022-01675-2","article-title":"PIM1\/STAT3 axis: a potential co-targeted therapeutic approach in triple-negative breast cancer","volume":"39","author":"Mahata","year":"2022","journal-title":"Med Oncol"},{"key":"10.1016\/j.modpat.2023.100323_bib34","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3390\/pharmaceutics14030498","article-title":"Choosing kinase inhibitors for androgen deprivation therapy-resistant prostate cancer","volume":"14","author":"Zhong","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.modpat.2023.100323_bib35","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s13577-021-00656-3","article-title":"A\u00a0systematic review on active sites and functions of PIM-1 protein","volume":"35","author":"Zhao","year":"2022","journal-title":"Hum Cell"},{"key":"10.1016\/j.modpat.2023.100323_bib36","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1182\/blood.2019003535","article-title":"Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report","volume":"135","author":"Lacy","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.modpat.2023.100323_bib37","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s11060-018-2990-6","article-title":"Characterization of genomic alterations in primary central nervous system lymphomas","volume":"140","author":"Zorofchian","year":"2018","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.modpat.2023.100323_bib38","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40478-016-0307-6","article-title":"TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy","volume":"4","author":"Munch-Petersen","year":"2016","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.modpat.2023.100323_bib39","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1038\/s41416-022-01762-1","article-title":"Aryl-hydrocarbon receptor-interacting protein regulates tumorigenic and metastatic properties of colorectal cancer cells driving liver metastasis","volume":"126","author":"Sol\u00eds-Fern\u00e1ndez","year":"2022","journal-title":"Br J Cancer"},{"key":"10.1016\/j.modpat.2023.100323_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2021.151742","article-title":"Aryl hydrocarbon receptor interacting protein (AIP) significantly influences prognosis of pancreatic carcinoma","volume":"53","author":"Fern\u00e1ndez-Ace\u00f1ero","year":"2021","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.modpat.2023.100323_bib41","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1007\/s12253-020-00863-7","article-title":"Prognostic role of aryl hydrocarbon receptor interacting protein (AIP) immunohistochemical expression in patients with resected gastric carcinomas","volume":"26","author":"D\u00edaz Del Arco","year":"2020","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.modpat.2023.100323_bib42","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.celrep.2019.04.014","article-title":"Aryl hydrocarbon receptor interacting protein maintains germinal center B cells through suppression of BCL6 degradation","volume":"27","author":"Sun","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.modpat.2023.100323_bib43","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1126\/science.284.5415.770","article-title":"Notch signaling: cell fate control and signal integration in development","volume":"284","author":"Artavanis-Tsakonas","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.modpat.2023.100323_bib44","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nrc3521","article-title":"The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer","volume":"13","author":"O\u2019Hayre","year":"2013","journal-title":"Nature Rev Cancer"},{"key":"10.1016\/j.modpat.2023.100323_bib45","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/ng.2468","article-title":"The genetic landscape of mutations in Burkitt lymphoma","volume":"44","author":"Love","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.modpat.2023.100323_bib46","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1073\/pnas.1121343109","article-title":"Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing","volume":"109","author":"Lohr","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.modpat.2023.100323_bib47","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1182\/bloodadvances.2019001012","article-title":"Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion","volume":"3","author":"Wienand","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.modpat.2023.100323_bib48","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.neo.2018.08.012","article-title":"Analysis of genomic alteration in primary central nervous system lymphoma and the expression of some related genes","volume":"20","author":"Zhou","year":"2018","journal-title":"Neoplasia"},{"key":"10.1016\/j.modpat.2023.100323_bib49","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1182\/blood-2011-07-367532","article-title":"Caspase-8 is essential for maintaining chromosomal stability and suppressing B-cell lymphomagenesis","volume":"119","author":"Hakem","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.modpat.2023.100323_bib50","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41417-018-0022-5","article-title":"Genomic landscape and prognostic analysis of mantle cell lymphoma","volume":"25","author":"Yang","year":"2018","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.modpat.2023.100323_bib51","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12885-022-09275-z","article-title":"The PI3K\/AKT\/mTOR signaling pathway is aberrantly activated in primary central nervous system lymphoma and correlated with a poor prognosis","volume":"20","author":"Zhang","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.modpat.2023.100323_bib52","doi-asserted-by":"crossref","first-page":"27471","DOI":"10.18632\/oncotarget.25463","article-title":"Target amplicon exome-sequencing identifies promising diagnosis and prognostic markers involved in RTK-RAS and PI3K-AKT signaling as central oncopathways in primary central nervous system lymphoma","volume":"9","author":"Takashima","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.modpat.2023.100323_bib53","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3390\/ijms17050683","article-title":"Gene mutation profiles in primary difuse large B cell lymphoma of central nervous system: next generation sequencing analyses","volume":"17","author":"Todorovic","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.modpat.2023.100323_bib54","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1200\/JCO.2015.64.9897","article-title":"Phase II trial of temsirolimus for relapsed\/refractory primary CNS lymphoma","volume":"34","author":"Korfel","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.modpat.2023.100323_bib55","first-page":"335","article-title":"Phase II study of single agent buparlisib in recurrent\/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL)","volume":"27","author":"Grommes","year":"2016","journal-title":"Ann Oncol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395223002284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395223002284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:25:31Z","timestamp":1760232331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395223002284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":55,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0893395223002284"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2023.100323","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genomic Profiling of Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System Suggests Novel Potential Therapeutic Targets","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2023.100323","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 United States & Canadian Academy of Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100323"}}